Switch to Qin Ouyang's research page...

2004

1. Ouyang Q, Wagner WM, Zheng W, Wikby A, Remarque EJ, Pawelec G. Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly. Exp Gerontol 39(4):607-13. (2004).
    [View Abstract - PubMed 15050296]  Request Paper

2003

2. Flad T, Schiestel T, Brunner H, Tolson J, Ouyang Q, Pawelec G, Mueller GA, Mueller CA, Tovar GE, Beck H. Development of an MHC-class I peptide selection assay combining nanoparticle technology and matrix-assisted laser desorption/ionisation mass spectrometry. J Immunol Methods 283(1-2):205-13. (2003).
    [View Abstract - PubMed 14659912]  Request Paper

3. Ouyang Q, Wagner WM, Voehringer D, Wikby A, Klatt T, Walter S, Muller CA, Pircher H, Pawelec G. Age-associated accumulation of CMV-specific CD8(+) T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp Gerontol 38(8):911-20. (2003).
    [View Abstract - PubMed 12915213]  Request Paper

4. Ouyang Q, Wagner WM, Walter S, Muller CA, Wikby A, Aubert G, Klatt T, Stevanovic S, Dodi T, Pawelec G. An age-related increase in the number of CD8(+) T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness. Mech Ageing Dev 124(4):477-85. (2003).
    [View Abstract - PubMed 12714256]  Request Paper

5. Ouyang Q, Wagner WM, Wikby A, Walter S, Aubert G, Dodi AI, Travers P, Pawelec G. Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J Clin Immunol 23(4):247-57. (2003).
    [View Abstract - PubMed 12959217]  Request Paper

6. Pawelec G, Ouyang Q. Immunosenescence in montecatini. Biogerontology 4(2):121-3. (2003).
    [View Abstract - PubMed 12766538]  Request Paper

7. Pawelec G, Ouyang Q, Wagner W, Biol D, Wikby A. Pathways to a robust immune response in the elderly. Immunol Allergy Clin North Am 23(1):1-13. (2003).
    [View Abstract - PubMed 12645875]  Request Paper

8. Wagner WM, Ouyang Q, Pawelec G. The abl/bcr gene product as a novel leukemia-specific antigen: peptides spanning the fusion region of abl/bcr can be recognized by both CD4+ and CD8+ T lymphocytes. Cancer Immunol Immunother 52(2):89-96. (2003).
    [View Abstract - PubMed 12594572]  Request Paper

2002

9. Ouyang Q, Wagner WM, Wikby A, Remarque E, Pawelec G. Compromised IFN-gamma production in the elderly leads to both acute and latent viral antigen stimulation: contribution to the immune risk phenotype? Eur Cytokine Netw 13(4):387-3. (2002).
    [View Abstract - PubMed 12517723]  Request Paper

10. Pawelec G, Ouyang Q, Colonna-Romano G, Candore G, Lio D, Caruso C. Is human immunosenescence clinically relevant? Looking for 'immunological risk phenotypes'. Trends Immunol 23(7):330-2. (2002).
     [View Abstract - PubMed 12103341]  Request Paper

11. Tarazona R, Solana R, Ouyang Q, Pawelec G. Basic biology and clinical impact of immunosenescence. Exp Gerontol 37(2-3):183-9. (2002).
     [View Abstract - PubMed 11772502]  Request Paper

12. Wagner WM, Ouyang Q, Pawelec G. Peptides spanning the fusion region of Abl/Bcr are immunogenic and sensitize CD8(+) T lymphocytes to recognize native chronic myelogenous leukemia. Leukemia 16(11):2341-3. (2002).
     [View Abstract - PubMed 12399986]  Request Paper

2000

13. Ouyang Q, Cicek G, Westendorp RG, Cools HJ, van der Klis RJ, Remarque EJ. Reduced IFN-gamma production in elderly people following in vitro stimulation with influenza vaccine and endotoxin. Mech Ageing Dev 121(1-3):131-7. (2000).
     [View Abstract - PubMed 11164467]  Request Paper

14. Pawelec G, Heinzel S, Kiessling R, Muller L, Ouyang Q, Zeuthen J. Escape mechanisms in tumor immunity: a year 2000 update. Crit Rev Oncog 11(2):97-133. (2000).
     [View Abstract - PubMed 11005508]  Request Paper